series-c-plus
Stage
1
Investors
About
Ethypharm is a specialty pharmaceutical company focused on developing, manufacturing, and marketing medicines primarily targeting central nervous system disorders such as severe pain and opioid addiction, as well as hospital injectables and internal medicine.
Explore Ethypharm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.